COVID-19 crisis: Modi govt's attempts to stifle criticism 'inexcusable', says Lancet editorial

-

Medical journal The Lancet on Saturday severely criticised the Narendra Modi government's handling of the COVID-19 crisis, saying that its actions in attempting to stifle criticism and open discussions are 'inexcusable'.

Referring to the large number of people seeking emergency assistance on social media, the editorial said, "...Before the second wave of cases of COVID-19 began to mount in early March, Indian minister of health Harsh Vardhan declared that India was in the “endgame” of the epidemic. The impression from the government was that India had beaten COVID-19 after several months of low case counts, despite repeated warnings of the dangers of a second wave and the emergence of new strains."

It further noted, "Modelling suggested falsely that India had reached herd immunity, encouraging complacency and insufficient preparation, but a serosurvey by the Indian Council of Medical Research in January suggested that only 21 percent of the population had antibodies against SARS-CoV-2."

"The Institute for Health Metrics and Evaluation estimates that India will see a staggering 1 million deaths from COVID-19 by 1 August. If that outcome were to happen, Modi's government would be responsible for presiding over a self-inflicted national catastrophe," the article remarked.

The Lancet editorial also slammed attempts to clamp down on citizens' SOS calls, saying that at times, the Modi government has seemed more intent on removing criticism on Twitter than trying to control the pandemic.

Last month, the Uttar Pradesh government had said that it would prosecute people under National Security Act for allegedly raising 'false alarms' on social media. This had attracted strong censure from the Supreme Court, which had said it would take contempt action against police officers who clamped down on citizens expressing their grievances.

The editorial on Saturday said that the country should rationalise its 'botched' vaccination campaign and implement it with all due speed.

"Genome sequencing needs to be expanded to better track, understand, and control emerging and more transmissible SARS-CoV-2 variants. Local governments have begun taking disease-containment measures, but the federal government has an essential role in explaining to the public the necessity of masking, social distancing, halting mass gatherings, voluntary quarantine, and testing," it said.

The Lancet editorial came on a day when India registered a record 4,187 COVID-19 deaths in 24 hours. A total of 4,01,078 new cases were reported during the same period, taking the caseload to 2,18,92,676.

 



from Firstpost India Latest News https://ift.tt/3o1sOsL
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more